Limited-stage small cell lung cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically or cytologically confirmed small cell lung cancer in limited-stage (IA to IIIB) 2. Responded to first treatment to complete response or good partial response (short axis of all mediastinal lymphnodes <15mm, no persisting primary lesion) 3. Confirmed absence of brain metastasis with enhanced cranial MRI within 2 months after the finish of initial treatment
Exclusion criteria
Exclusion criteria: 1. Patients with brain metastasis 2. Patients judged as inappropriate for this study by investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of brain metastasis | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival time, Quality of life (QCQ-C30/BN20), cognitive ability (MMSE) | — |
Countries
Japan
Contacts
Hamamatsu Univ. School of Medicine Department of Internal Medicine, second division